CI Investments Inc. increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 17.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 336,170 shares of the financial services provider’s stock after acquiring an additional 50,392 shares during the period. CI Investments Inc.’s holdings in CME Group were worth $57,219,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CME. First Citizens Bank & Trust Co. boosted its holdings in CME Group by 1.4% in the third quarter. First Citizens Bank & Trust Co. now owns 20,939 shares of the financial services provider’s stock worth $3,564,000 after acquiring an additional 295 shares in the last quarter. Oak Ridge Investments LLC boosted its holdings in CME Group by 6.2% in the second quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock worth $860,000 after acquiring an additional 306 shares in the last quarter. MayTech Global Investments LLC boosted its holdings in CME Group by 0.7% in the second quarter. MayTech Global Investments LLC now owns 50,090 shares of the financial services provider’s stock worth $8,211,000 after acquiring an additional 338 shares in the last quarter. BB&T Corp boosted its holdings in CME Group by 8.2% in the third quarter. BB&T Corp now owns 4,546 shares of the financial services provider’s stock worth $774,000 after acquiring an additional 343 shares in the last quarter. Finally, Checchi Capital Advisers LLC boosted its holdings in CME Group by 8.0% in the third quarter. Checchi Capital Advisers LLC now owns 4,899 shares of the financial services provider’s stock worth $834,000 after acquiring an additional 363 shares in the last quarter. 85.79% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently weighed in on CME shares. Keefe, Bruyette & Woods restated a “hold” rating and issued a $184.00 target price on shares of CME Group in a report on Monday, December 10th. Zacks Investment Research lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday, December 7th. Barclays started coverage on CME Group in a report on Tuesday, December 4th. They issued an “overweight” rating and a $210.00 target price on the stock. Atlantic Securities started coverage on CME Group in a report on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 target price on the stock. Finally, UBS Group lowered CME Group from a “buy” rating to a “neutral” rating and raised their target price for the company from $185.00 to $204.00 in a report on Wednesday, November 28th. Seven investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. CME Group presently has an average rating of “Buy” and an average price target of $193.50.

In related news, insider Julie Winkler sold 5,847 shares of CME Group stock in a transaction on Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the sale, the insider now directly owns 24,255 shares in the company, valued at $4,729,967.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 2,800 shares of CME Group stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $183.45, for a total value of $513,660.00. The disclosure for this sale can be found here. Insiders have sold 43,187 shares of company stock worth $8,200,117 over the last quarter. 0.43% of the stock is currently owned by corporate insiders.

Shares of CME Group stock opened at $185.59 on Tuesday. The firm has a market cap of $63.77 billion, a P/E ratio of 38.91, a price-to-earnings-growth ratio of 2.52 and a beta of 0.46. CME Group Inc has a 12 month low of $143.68 and a 12 month high of $197.08. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.09.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, topping the Zacks’ consensus estimate of $1.42 by $0.03. The business had revenue of $904.20 million for the quarter, compared to analyst estimates of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. Research analysts anticipate that CME Group Inc will post 6.66 EPS for the current year.

The firm also recently declared a dividend, which will be paid on Wednesday, January 16th. Investors of record on Friday, December 28th will be issued a dividend of $1.75 per share. The ex-dividend date of this dividend is Thursday, December 27th. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

COPYRIGHT VIOLATION WARNING: “CME Group Inc (CME) Position Raised by CI Investments Inc.” was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.dailypolitical.com/2018/12/18/cme-group-inc-cme-position-raised-by-ci-investments-inc.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: What are the reasons investors use put options?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.